Stable pharmaceutical compositions
AssigneeBarbeau Pharma, Inc.
InventorDonald L. Barbeau
Life of this patent
Estimating the term…
Loading patent…
AssigneeBarbeau Pharma, Inc.
InventorDonald L. Barbeau
Estimating the term…
A method of improving the stability of a hydralazine composition during manufacturing or storage comprising coupling an N-protecting group with hydralazine to produce the compound having the formula: 1 or a compound having the formula: 2 where R1 and R2 are independently H, branched or straight chain alkyl having from 1 to about 7 carbon atoms, substituted or unsubstituted aryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted alkylcycloalkyl, lower alkenyl or R1 and R2 together form part of a substituted or unsubstituted cycloalkyl having from about 4 of about 7 carbon atoms; where R3 is a branched or straight chain alkyl having from 1 to about 7 carbon atoms, substituted or unsubstituted aryl, substituted or unsubstituted aralkyl, substituted or unsubstituted cycloalkyl, aralkyl, substituted or unsubstituted alkylcycloalkyl or a group having the formula (CH2)nCOOH where n is from 1 to about 7.
A method of improving the stability of a hydralazine composition during manufacturing or storage comprising coupling an N-protecting group with hydralazine to produce a compound having the formula:
A compound having the formula:
A particulate-free hydralazine composition comprising compound having the formula:
A metal ion-free hydralazine composition comprising a compound having the formula:
Dependencies are inferred from the claim text.